See the DrugPatentWatch profile for Follitropin
What is follitropin alfa?
Follitropin alfa is a fertility medicine that is a laboratory-made version of follicle-stimulating hormone (FSH). FSH helps the ovaries in women develop follicles and helps support processes needed for ovulation and conception. In men, FSH helps support sperm production. (The same medicine is often marketed under brand names that vary by country.)
What is it used for in women?
Clinicians use follitropin alfa to treat conditions where FSH is needed to stimulate follicle development. Common clinical goals include:
- Inducing ovulation in people who do not ovulate or who have irregular ovulation, typically after or alongside other medicines depending on the patient’s situation.
- Supporting controlled ovarian stimulation in fertility treatment, such as IVF, where follicle growth is needed to retrieve eggs.
What is it used for in men?
In men, follitropin alfa is used when infertility is linked to insufficient FSH activity, most often as part of a sperm-production regimen. It is generally used together with other hormones rather than by itself, depending on the diagnosis.
How is follitropin alfa given?
Follitropin alfa is given by injection. In fertility care, the dose and schedule are individualized based on factors such as:
- Age and fertility diagnosis
- Ovarian response (in people who can become pregnant)
- Blood hormone levels and ultrasound findings during treatment
Clinicians monitor response during treatment to adjust dosing and timing.
What side effects do people report?
Side effects depend on the dose, the fertility setting, and individual risk factors. Patients may experience injection-site reactions and typical hormone-related effects. A key safety concern in fertility stimulation is the risk of ovarian hyperstimulation syndrome (OHSS) in people undergoing ovarian stimulation, especially if the response is higher than expected.
What happens if the dose is too high or the response is too strong?
If ovarian response is excessive during stimulation, clinicians may:
- Adjust or stop dosing
- Change timing of trigger medication
- Increase monitoring
These steps are used to reduce the risk of OHSS and other complications related to overstimulation.
How does follitropin alfa compare with other FSH products?
Follitropin alfa is one of several recombinant FSH products used for ovarian stimulation and male fertility indications. They differ by brand, formulation, dosing units, and prescribing practices. Patients typically do not “switch for effectiveness” without a clinical reason, because response depends more on individual physiology and how clinicians titrate dosing than on the brand alone.
Who makes follitropin alfa?
Brand ownership and manufacturing can vary by market and product presentation, so the manufacturer name depends on the specific brand in a given country.
What should patients ask their clinician?
Patients often ask about:
- The starting dose and how it will be adjusted
- How frequently they will be monitored (blood tests and ultrasound)
- OHSS risk and what symptoms to watch for
- Whether there is a plan if the response is too low
- The trigger timing and what that means for egg retrieval or ovulation timing
Sources
No provided references were included in your message, so I can’t cite specific guidelines, labeling, or brand details. If you tell me the brand name (or country) and what you’re trying to use it for (IVF vs ovulation induction vs male infertility), I can give a tighter, more targeted answer.